Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19275248 | SYSTEM AND METHOD FOR DELIVERING MEDICATION AND MEDICAL SUPPLIES TO PERSONS IN NEED THEREOF IN RESPONSE TO A LARGE SCALE EMERGENCY SCENARIO | July 2025 | January 2026 | Allow | 6 | 0 | 0 | Yes | No |
| 19074848 | CREATING AND MANAGING PROBLEM LISTS FOR ELECTRONIC HEALTH RECORDS | March 2025 | April 2025 | Allow | 2 | 0 | 0 | Yes | No |
| 19044337 | ELECTRONIC HEALTHCARE RECORD DATA BLOCKCHAIN SYSTEM AND PROCESS | February 2025 | March 2026 | Allow | 13 | 0 | 0 | Yes | No |
| 18975915 | MEDICAL QUESTION ANSWERING SYSTEM | December 2024 | November 2025 | Allow | 11 | 2 | 0 | Yes | No |
| 18923509 | SYSTEM AND METHOD FOR DELIVERING MEDICATION AND MEDICAL SUPPLIES TO PERSONS IN NEED THEREOF IN RESPONSE TO A LARGE SCALE EMERGENCY SCENARIO | October 2024 | December 2025 | Abandon | 13 | 2 | 0 | Yes | No |
| 18649283 | CREATING AND UPDATING PROBLEM LISTS FOR ELECTRONIC HEALTH RECORDS | April 2024 | December 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18614123 | RETRIEVING DICOM IMAGES | March 2024 | September 2025 | Allow | 17 | 0 | 0 | Yes | No |
| 18608615 | SYSTEM AND METHOD FOR SCHEDULING PATIENT APPOINTMENTS | March 2024 | September 2025 | Allow | 18 | 0 | 0 | Yes | No |
| 18595305 | ELECTRONIC HEALTHCARE RECORD DATA BLOCKCHAIN SYSTEM AND PROCESS | March 2024 | September 2024 | Allow | 7 | 0 | 0 | Yes | No |
| 18419830 | COMPUTER-BASED SYSTEMS CONFIGURED FOR REAL-TIME AUTOMATED DATA INDEXING OF RESOURCES ACROSS DISPARATE ELECTRONIC PLATFORMS AND METHODS OF USE THEREOF | January 2024 | August 2024 | Allow | 7 | 0 | 0 | Yes | No |
| 18467357 | PATIENT TREATMENT STATUS NOTIFICATION SYSTEM | September 2023 | December 2025 | Allow | 27 | 4 | 0 | Yes | No |
| 18455468 | SYSTEMS AND METHODS FOR LONGITUDINAL TIMELINE PRESENTATION AND PREDICTIVE CLINICAL DECISION SUPPORT | August 2023 | January 2026 | Allow | 29 | 1 | 0 | Yes | No |
| 18546371 | NOTIFICATION DEVICE, NOTIFICATION METHOD AND PROGRAM | August 2023 | March 2026 | Abandon | 31 | 1 | 0 | No | No |
| 18362950 | METHOD AND SYSTEM FOR DISCOVERING NEW DRUG INDICATION BY FUSING PATIENT PORTRAIT INFORMATION | July 2023 | December 2024 | Abandon | 16 | 3 | 0 | Yes | No |
| 18271798 | ELECTRONIC HEALTH RECORDS READER | July 2023 | January 2026 | Abandon | 30 | 1 | 0 | No | No |
| 18212562 | SYSTEM AND METHOD FOR AUTOMATIC DISPLAY OF CONTEXTUALLY RELATED DATA ON MULTIPLE DEVICES | June 2023 | January 2026 | Allow | 31 | 2 | 0 | Yes | No |
| 18335446 | HEALTH RISK REDUCTION METHOD, HEALTH RISK REDUCTION SYSTEM, AND HEALTH RISK REDUCTION PROGRAM | June 2023 | January 2026 | Abandon | 31 | 1 | 0 | Yes | No |
| 17906959 | ANIMAL PATIENT INSPECTION SUGGESTION SYSTEM, ANIMAL PATIENT INSPECTION SUGGESTION TERMINAL, AND ANIMAL PATIENT INSPECTION SUGGESTION PROGRAM | March 2023 | February 2026 | Abandon | 41 | 1 | 0 | No | No |
| 18100853 | METHODS AND SYSTEMS FOR DETERMINATION OF TREATMENT THERAPEUTIC WINDOW, DETECTION, PREDICTION, AND CLASSIFICATION OF NEUROELECTRICAL, CARDIAC, AND/OR PULMONARY EVENTS, AND OPTIMIZATION OF TREATMENT ACCORDING TO THE SAME | January 2023 | January 2026 | Abandon | 36 | 2 | 0 | No | No |
| 18090411 | APPARATUS AND METHOD FOR SCORING A NUTRIENT | December 2022 | May 2025 | Allow | 29 | 5 | 0 | Yes | No |
| 18065001 | INFORMATION PROCESSING METHOD AND INFORMATION PROCESSING DEVICE | December 2022 | March 2025 | Abandon | 27 | 0 | 1 | No | No |
| 18077278 | GENERATING A RECOMMENDED HEALTHCARE DECISION PROCESS | December 2022 | March 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18008553 | AN ONLINE HEALTH-RELATED SERVICES PLATFORM AND A METHOD PROVIDING THEREOF | December 2022 | October 2025 | Abandon | 35 | 2 | 0 | No | No |
| 17819116 | DATA PROCESSING APPARATUS AND METHOD | August 2022 | January 2026 | Abandon | 41 | 3 | 0 | No | No |
| 17884936 | METHOD AND APPARATUS FOR GENERATING A CIRCUIT PROTOCOL FOR INSTITUTING A DESIRED BODY MASS INDEX | August 2022 | November 2024 | Abandon | 27 | 7 | 0 | Yes | No |
| 17872719 | Systems and methods for monitoring brain health status | July 2022 | March 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17812727 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM | July 2022 | July 2025 | Abandon | 36 | 2 | 0 | No | No |
| 17785103 | SYSTEM AND METHOD FOR CONFIGURING DATA COLLECTION FOR A DIGITAL TWIN | June 2022 | January 2026 | Allow | 43 | 4 | 0 | Yes | Yes |
| 17744273 | SYSTEM AND METHOD FOR TRANSLATING MEDICAL LABORATORY DATA INTO ACTIONABLE INFORMATION | May 2022 | February 2025 | Abandon | 33 | 1 | 0 | No | No |
| 17772663 | METHOD AND SYSTEM FOR AN INTERFACE TO PROVIDE ACTIVITY RECOMMENDATIONS | April 2022 | January 2026 | Abandon | 44 | 3 | 0 | No | No |
| 17688215 | Determining Prognosis and Treatment based on Clinical-Pathologic Factors and Continuous Multigene-Expression Profile Scores | March 2022 | August 2025 | Abandon | 41 | 2 | 0 | Yes | No |
| 17635982 | APPLICATION FOR TRACKING PROGRESSION AND ISOLATING CAUSES OF ADVERSE MEDICAL CONDITIONS | February 2022 | November 2025 | Abandon | 45 | 4 | 0 | No | No |
| 17609837 | CLINICAL DECISION SUPPORT | November 2021 | February 2026 | Abandon | 51 | 4 | 0 | Yes | No |
| 17517902 | Automatic Prescription Medication Scheduling | November 2021 | April 2025 | Abandon | 41 | 2 | 0 | Yes | Yes |
| 17401898 | Video Documentation System and Medical Treatments Used with or Independent Thereof | August 2021 | September 2025 | Abandon | 49 | 6 | 0 | No | No |
| 17289813 | Big Data-Driven Personalized Management of Chronic Pain | April 2021 | February 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17287368 | DECISION SUPPORT SOFTWARE SYSTEM FOR SLEEP DISORDER IDENTIFICATION | April 2021 | May 2025 | Abandon | 49 | 4 | 0 | No | No |
| 17198274 | MEDICAL SYSTEM AND CONTROL METHOD THEREOF | March 2021 | March 2025 | Abandon | 48 | 4 | 0 | Yes | Yes |
| 17190102 | METHOD AND SYSTEM FOR MONITORING OPERATION OF INSTRUMENTS USING A TRANSCEIVER OVER A COMMUNICATION NETWORK | March 2021 | March 2025 | Abandon | 57 | 5 | 0 | No | No |
| 17154291 | MEDICAL REPORTING ASSISTANCE APPARATUS AND MEDICAL REPORTING ASSISTANCE METHOD | January 2021 | March 2025 | Abandon | 50 | 6 | 0 | No | No |
| 17130719 | DIABETES COMPLICATION PREDICTION BY HEALTH RECORD MONITORING | December 2020 | April 2025 | Allow | 52 | 4 | 0 | Yes | No |
| 17118294 | SELECTING, QUEUING, AND DISPATCHING REMOTELY LOCATED PATIENT SERVICE PROVIDERS | December 2020 | May 2025 | Abandon | 53 | 4 | 0 | Yes | Yes |
| 16973436 | INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING DEVICE, AND INFORMATION PROCESSING METHOD | December 2020 | July 2025 | Abandon | 55 | 4 | 0 | Yes | No |
| 17054554 | SYSTEM AND METHOD FOR PROVIDING MODEL-BASED PREDICTIONS OF ACTIVELY MANAGED PATIENTS | November 2020 | November 2024 | Abandon | 48 | 3 | 0 | No | No |
| 17069639 | SYSTEMS AND METHODS FOR PROCESSING PAPER BILLS | October 2020 | August 2025 | Abandon | 58 | 2 | 0 | Yes | Yes |
| 17036022 | ELECTRONIC HEALTHCARE PLATFORM THAT PROVIDES PERSONALIZED RECOMMENDATIONS FOR PERSONAL CARE PRODUCTS AND HEALTHCARE SERVICES | September 2020 | October 2024 | Abandon | 49 | 2 | 0 | No | No |
| 17015265 | CLOUD-BASED PATIENT DATA EXCHANGE | September 2020 | September 2025 | Abandon | 60 | 6 | 0 | Yes | No |
| 17001589 | SYSTEMS AND METHODS FOR FEDERATED SEARCHING AND RETRIEVAL OF MEDICAL RECORDS ACROSS DISPARATE DATABASES | August 2020 | June 2025 | Abandon | 58 | 5 | 0 | No | No |
| 16959501 | METHOD, APPARATUS, ELECTRONIC DEVICE AND INTERACTIVE METHOD FOR CORRECTING MEASURED DATA, COMPUTER READABLE MEDIUM AND MEASURING DEVICE | July 2020 | May 2025 | Abandon | 58 | 5 | 0 | No | No |
| 16811191 | Anticipatory Analytics Processing of Electronic Medical Records | March 2020 | December 2025 | Abandon | 60 | 5 | 0 | Yes | Yes |
| 15851982 | DETERMINING ACTIONABLE EVENTS FOR GAMIFIED HEALTH GOALS BASED UPON USER COMMUNICATIONS | December 2017 | November 2024 | Abandon | 60 | 5 | 0 | No | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HUYNH, EMILY.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner HUYNH, EMILY works in Art Unit 3683 and has examined 19 patent applications in our dataset. With an allowance rate of 5.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 52 months.
Examiner HUYNH, EMILY's allowance rate of 5.3% places them in the 1% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by HUYNH, EMILY receive 4.11 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by HUYNH, EMILY is 52 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +11.1% benefit to allowance rate for applications examined by HUYNH, EMILY. This interview benefit is in the 45% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 2.2% of applications are subsequently allowed. This success rate is in the 1% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 3% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 19% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 0.0% of appeals filed. This is in the 2% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 6% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.